Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
america publishing date : 2022 - 03 - 08 save search
Xencor to Present Preclinical Data from XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
XNCR | $19.08 0.85% 0.84% 450K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
xmab america program research preclinical cancer pre-clinical
Exscientia to Highlight Precision Medicine Platform and Pipeline Data at the American Association of Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - biospace.com/
EXAI | $4.32 1.65% 1.62% 430K
|
|
| O: 0.0%
H: 14.63%
C: 12.76%
america research cancer platform
Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - globenewswire.com
CNTX | $1.38 -5.48% -5.8% 34K
|
Health Technology
|
| O: 3.21%
H: 7.21%
C: 6.21%
therapeutics america ces research cancer
Richmond American Set to Expand in Lake County
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
MDC | $62.95 -0.02% 0.0% 2.1M
|
Consumer Durables
|
| O: 2.21%
H: 2.83%
C: 0.26%
america set
Theseus Pharmaceuticals to Present Preclinical Data Characterizing Next-Generation Epidermal Growth Factor Receptor (EGFR) Inhibitors at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
THRX | $4.06 0.49% 0
|
|
| O: 2.4%
H: 8.76%
C: 4.68%
america als derm research preclinical cancer growth pre-clinical
Omega Therapeutics to Present Preclinical Data for OTX-2002 at the American Association for Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
OMGA | $2.565 6.43% 6.04% 390K
|
|
| O: 2.36%
H: 0.0%
C: 0.0%
otx-2002 america research therapeutics preclinical cancer pre-clinical
Arcellx Announces Pre-Clinical Data Presentation for ACLX-002, a Novel CD123-targeted Universal CAR-T Cell Therapy for Relapsed or Refractory Acute Myeloid Leukemia at the American Association for Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
ACLX | $53.52 -3.08% -3.18% 440K
|
|
| O: 2.8%
H: 3.41%
C: -6.98%
aclx-002 america myeloid leukemia car-t leukemia research presentation cel pre-clinical therapy cancer t-cell preclinical acute myeloid leukemia
Adagene Announces Four Poster Presentations on Robust Preclinical Pipeline of Antibody-Based Therapeutics at Upcoming American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 23:00) - globenewswire.com
ADAG | $2.69 -0.37% -0.37% 11K
|
Manufacturing
|
| O: 1.25%
H: 8.84%
C: -2.24%
america pos research therapeutics presentation preclinical cancer antibody pre-clinical
Catalyst Pharmaceuticals Named Among Forbes 2022 America's Best Small Companies
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
CPRX | $15.99 2.9% 2.81% 1.4M
|
Health Technology
|
| O: -0.26%
H: 1.3%
C: -2.73%
america als
Bio-Path Holdings to Present at the 2022 American Association for Cancer Research Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
BPTH | $3.235 6.07% 5.72% 710K
|
Health Technology
|
| O: 3.38%
H: 4.17%
C: 4.17%
america research cancer
Kronos Bio’s Investigational CDK9 Inhibitor KB-0742 to be Featured in Four Preclinical Poster Presentations at American Association for Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
KRON | $1.03 -5.51% -5.83% 190K
|
Health Technology
|
| O: 2.13%
H: 6.85%
C: 6.25%
kb-0742 america pos research presentation preclinical cancer pre-clinical
C4 Therapeutics to Present at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
CCCC | $6.89 0.88% 0.87% 1.2M
|
Health Technology
|
| O: 5.67%
H: 11.76%
C: 9.1%
america research therapeutics cancer
Iovance Biotherapeutics to Present at American Association for Cancer Research (AACR) 2022 Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
IOVA M | $11.8 -1.01% -1.02% 3.1M
|
Health Technology
|
| O: 2.21%
H: 6.63%
C: 5.78%
america research therapeutics cancer iot
Olema Oncology Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
OLMA | $10.72 -0.92% -0.93% 510K
|
Health Technology
|
| O: 2.97%
H: 10.42%
C: 8.65%
america ema pos research presentation cancer
American Assets Trust, Inc. Acquires Bel-Spring 520 Office Campus in Bellevue, Washington
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
AAT | $20.46 0.49% 0.0% 210K
|
Finance
|
| O: 0.14%
H: 1.32%
C: -1.32%
america trust set
Amlan International Strengthens Brazilian Presence by Appointing Eduardo Euclides Baggio as Technical Manager
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
ODC | News | $70.51 1.63% 0.0% 20K
|
Process Industries
|
| O: 0.42%
H: 2.49%
C: 1.45%
brazil
ORIC Pharmaceuticals Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
ORIC | $9.79 3.6% 3.47% 510K
|
Health Technology
|
| O: 0.43%
H: 13.86%
C: 8.57%
america als research presentation cancer
Checkmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
CMPI | $10.5 0.0%
|
Health Technology
|
| O: 6.56%
H: 0.29%
C: 0.0%
america als research cancer
Nykode Therapeutics to Present at 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
NKTR | News | $1.345 -9.73% -10.78% 3.3M
|
Health Technology
|
| O: 5.13%
H: 4.78%
C: 1.66%
america research therapeutics cancer
Rubius Therapeutics to Present Updated Results from Single-Agent Phase 1 Clinical Trial of RTX-240 at the American Association of Cancer Research Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: 2.12%
H: 20.58%
C: 19.33%
rtx-240 america research trial therapeutics phase 1 results cancer
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.